(Q33682941)

English

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

S Li

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

L Li

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Y Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

C Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Y Qin

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

H Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

L Ren-Heidenreich

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

B Shi

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

H Ren

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

X Chu

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

J Kang

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

W Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

J Xu

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

K Tang

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

H Yang

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Y Zheng

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

J He

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

G Yu

18

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

N Liang

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

17 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2812-2820

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in exon 20 (S768I).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Second-hand smoke and human lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

28 July 2018

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Uncommon V599E BRAF mutations in Japanese patients with lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

EGFR mutation and response of lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

RAF/RAS oncogenes and mismatch-repair status

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.210

21 January 2018

Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

30 October 2018

Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

30 October 2018

A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037826

30 October 2018

A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769L

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2014.210

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33682941&oldid=2195639432"